17β-estradiol
43,44
50,51
53,54
56,57
70,71
88,89
AMPK
AP1/SP1 sites
APP
AS160
ATP
Aberrant
Activating
Administration
Akt
Akt (
Akt-FoxO1 signaling
Akt-PGC1α
Akt-reduced
Alzheimer’s disease
Alzheimer’s disease
Akt
Protein kinase B
AMPK
AMP-activated protein kinase
Aromatase
Author information
•	Article
BDNF
BNIP3
Biological sex
British physiologist
C2C12 cells
CBP
CBP/P300
CREB
CREB-
CREB-binding protein
CRTC2
CVD
CVD-related
Cdc2-like kinase 2
Clinical cross-sectional study
Clinical study
Clk2
Constant
DMD
DNA binding
DNL
Diabetes
Drp1
Drug Administration
Duchenne muscular dystrophy
Dynamin-related protein 1
Dysregulated insulin
Dysregulation
E2-
E2-ERα
E2-GPER-PKA
E2-induced and ERα-mediated glucose transporter 4
ERE
ERK
ERK1/2
ERs
ERα
ERα cascade
ERα controlled
ERα function
ERα protein
ERα signaling
ERα transcriptional regulation
ERα-
ERα-Akt-GSK3
ERα-Mc4r gene
ERα-PI3K-Akt-FoxO1 cascade
ERα/ERβ
ERβ
ESR1
Energy sensors
Ernest
Erα
Estrogen
Estrogen deficiency
Estrogen signaling
Estrogen signaling fine-tunes protein
Estrogen therapy
Estrogen-ERα
Estrogens
Estrogen–ER
Estrone
FGF21
Females
Fgf21
Fgf21 promoter
Figure
Figure 1A
Figure 1B
Figure 2A
Fis1
Food
Forkhead box O
FoxO
FoxO1
FoxO1 triple
FoxO3
FoxO4
FoxOs
FoxOs activity
FoxOs-Sestrin-mTOR cascade
FoxOs-Sestrins-mTOR cascade
FoxOs-independent
FoxOs-mediated
FoxOs-mediated Tfam
G-coupled protein
G6Pase
GIP
GIP receptor
GLP-1
GLP1 receptor
GLUT
GLUT1
GLUT4
GPER
GPER agonist
GSK3
Gai
Global knockout ERα
HFD
HFD-induced
HMDCs
Heat shock protein
High fat
Hormonal regulation
Hormonal signaling
IHTG
IRS
IRS promotor
IRS-1
IRS-2
IRS-PI3K-Akt pathway
IRS-PI3K-Akt regulation
IRS-PI3K-Akt-FoxOs signaling cascade
IRS-PI3K-PDK1-Akt
IRS-PI3K-PDPK1-aPKCλ
IRS-mediated
IRS1
IRS1
insulin receptor
IRS1-PI3K-PDK1-Akt-AMPK
IRS1/2
IRS1/2 double
IRS2
IRSs
IRS→PI3K→FoxO1
Impaired
Inflammation
Insulin
Insulin administration
Insulin dysregulation
Insulin level
Insulin signaling
Insulin therapy
Irs1
Irs2
JNK
Japanese
Keywords
L-F1KO) mice
License information
PMCID
LncRNA
Mapping
Mc4r
Membrane ERα
Mfn1/2
Mirabegron
Mitochondrion
Mounjaro (tirzepatide
MuRF1 protein
Muscle
N-terminal kinase
NAFLD
NRF1
Nr4a1
OVX
Obesity
PAK
PAK1
PAK1
p21
PAK1/2
p21
PAK1/2 signaling
PAK2
PDPK1-aPKCλ branch
PEPCK
PGC-1α
PGC1α
PGC1α-dependent
PI3K
PI3K
phosphoinositide 3-kinase
PI3K-Akt
PI3K-Akt pathway
PI3K-Akt-FoxO1
PI3K-Akt-FoxO1 signaling
PI3K-Akt-FoxOs
PI3K/Akt signaling
PINK1
PKA
PPARα-PPARδ agonist
Parkinson’s disease
Polg1
Prolonged
Proteasomal
Protein turnover
RAC1
RAF proto-oncogene
RNA
Clk2
Rictor
SMI
SREBP1c
STZ
Sarcopenia
Ser1101
Ser1149
Ser21
Ser256
Ser473
Ser9
Sestrin1
Sestrin2
Sestrin3
Sestrins
Sestrins-mTOR signaling node
Sex difference
Sirt1
Slug
Snail
Src
Starling
Studies
T allele
T1DM
T2D
T2DM
TSC
TSC2-dependent
Tau
Tfam
Thr308
Thr64
Treatment
Type 1 diabetes mellitus
Type 2 diabetes
Type 2 diabetes mellitus
Tyr612
Ucp1
aberrant
absent
accelerated
actin
actin proteins
action
activate
activated
activated kinase
activated kinase 1
activated kinase 2
activates
activating
activation
active cystines
active profile
acute
acute insulin stimulation
adequate
adipocyte
adipocytes
adipogenesis
adipose tissue
adiposity
administration
adults
adverse effects
affecting
age
age-dependent vascular dysfunction
agonists
ameliorating
amino acids
amnestic
amyloid peptide
amyloid precursor protein
amyloid precursor protein
AS160
animal models
animal studies
animals
apoptosis
apple-shaped
approval
associated with
atherosclerosis
attenuated
atypical protein kinase C λ
APP
autoimmune disease
autophagic degradation pathway
autophagy
availability to
balanced
benefits
binding
binds
biochemical processes
biogenesis
biological
biotechnology-assisted synthesis
bladder
bloating abdomen
blood circulatory system
blood sugar
body fat
body weight
boosts
brain
brain functions
brain responds
brain-derived neurotrophic factor
brains
breakdown
breast cancer
brown
brown adipose tissue
c-Jun
cAMP response element-binding protein
cAMP-PKA
cAMP-PKA-CREB pathway
cAMP-induced
cancer cells
canonical
canonical IRS-PI3K-Akt
canonical IRS-PI3K-PDK1-Akt
canonical insulin signaling
canonical insulin signaling pathways
cardiac conditions
cardiac insulin
cardiometabolic
cardiomyocyte
cardiovascular
cardiovascular disease
cardiovascular diseases
catalytic subunit
catalyzes
cause
caveolin-1
ceRNA
cell plasticity
cells
cellular
cellular metabolism
cellular remodeling
cerebral bioenergetics
characterization
characterized
cholesterol
clearance
clinical application
clinical research
clinical study
clinical treatments
clinical trial
clinical trials
cognitive
cognitive impairment
combination
comorbidities
compared
comparison
compensatory
complex
constant
contact with
content
contractile proteins
control mice
control system
controlling
controls
convergence
converges
conversion
coordinating
critical mediators
cross-talk
cytokines
cytoplasm
cytosolic ERα
damaged
de novo lipogenesis
deacetylase activity
deacetylates
deacetylation
deactivated
deactivation
deal
decrease
decreased
decreases
defense
definition
degeneration
degradation
degrees
delayed
delayed myoregeneration
dendritic spine formation
dephosphorylation
depicts
derangement
derangements
designing
detrimental
detrimental effects
development
diabetes
diabetic
diabetic cardiomyopathy
diabetic muscle disease
diacylglycerol acyltransferase inhibitor
difference
dimerization
diminish
disability
discovered
discovery
disease
disease status
diseased state
diseased striated muscle
diseases
distribution
dopamine
double-blind
down-regulate Akt
down-regulate fission protein
downstream
downstream pathways
downstream protein kinases
drug efficacy
drugs
dual GLP1/GIP receptor agonist
duration
dynamics
dynamin-related protein 1
dysfunctional
dysfunctional estrogen signaling
eNOS
early
early detection
early stages
effects
efficacy
elevated
elimination
encode
endogenous
endoplasmic-reticulum-associated protein degradation system
endothelial
endothelial-derived nitric oxide
energy expenditure
energy metabolism
energy production
energy sensor
enzyme
epigenetic
epigenetic programming
essential
essential signaling pathways
estradiol
estradiol-ER signaling
estriol (E3
estrogen
estrogen
Zhipeng Tao 1
estrogen administration
estrogen levels
estrogen prevents
estrogen receptor
estrogen receptors
estrogen response elements
estrogen restored
estrogen secretion
estrogen sensitive
estrogen signaling
estrogen signaling cascades
estrogen signaling converge
estrogen signaling pathways
estrogen synthesis
estrogen treatment
estrogen-ER signaling
estrogen-FoxO1 axis
estrogenic hormonal activity
estrogens
ethnicity
evaluate
evidence
exercise
experimental agents
experimental models
experimental subjects
expression
expressions
extragonadal tissues
factor
factors
fasting
fasting cycle
fatty acids
fatty liver disease
feasibility
feeding
feeding state
feeding status
feeding-fasting cycle
female
female brain
female mice
female reproductive system
female sex hormones
females
fibroblast growth factor
fibroblast growth factor 21
finding
findings
fine-tune glucose mentalism
fine-tune whole body function
fission
food aversion
food intake
force
formation
function
functional
functions
fusion
fusion proteins
gender
gender difference
genders
gene
gene
FoxO1
Forkhead Box O1
FoxO3
Forkhead Box O3
FoxO4
Forkhead Box O4
G6Pase
glucose-6-phosphatase
Gai
G-coupled protein
gene expression
gene transcription
general neuronal health
genetic
genetic polymorphisms
genetically predisposed
glands
global level
glucagon-like peptide-1
glucagon-to-insulin ratio
glucocorticoid receptor
glucokinase
gluconeogenesis
gluconeogenic genes
glucose
glucose disposal ability
glucose homeostasis
glucose intolerance
glucose metabolism
glucose production
glucose tolerance
glucose transporter 1
glucose uptake
glucose uptake/metabolism
glucose utilization
glucose-6-phosphatase
glucose-dependent insulinotropic polypeptide
glucose-stimulated/high-insulin lipogenesis
glycemic control
glycogen production
glycogen synthase kinase-3
HFD
high fat diet
glycogen synthesis
glycogenolysis
glycolysis
glycolytic extensor digitorum longus muscle
glycosylated
glycosylation
good
govern gene
group
group I
hallmarks
health
healthy
heart
heat shock protein 90
hepatic
hepatic ERα
hepatic gluconeogenesis
hepatic glucose
hepatic steatosis
high fat
high-protein-turnover state
hippocampal
hippocampus
homeostasis
hormonal
hormonal signaling pathways
hormone
hormone discovery
hormone replacement treatment
hormone research
hormones
human
humans
hyperglycemia
hypoestrogenaemia
immobilization
immune system destroys
immunometabolic function
impaired
impairs
improvement
improves
inactivating
increase
increased
increases
independent
individuals
induce
induced
induces
inflammation
influence
influenced
inhibit
inhibited
inhibiting
inhibitor
inhibits
injured
insensitive tissue
insulin
insulin administration device
insulin analogues
insulin concentrations
insulin deficiency
insulin dysfunction
insulin exposure
insulin function
insulin plus
insulin receptor
insulin resistance
insulin secretion
insulin sensitivity
insulin signaling
insulin signaling pathway
insulin signaling pathways
insulin treatment
insulin-producing β cells
insulin-sensitive tissues
insulin-stimulated
insulin-stimulated glucose
insulin-stimulated muscle
integrity
interact
interaction
interferes
internal secretion
interplays
intertwined
intervention
intrahepatic triglyceride
intramyocellular diacylglycerol
intranasal insulin therapy
investigate
investigation
investigations
involvement
isoforms
joint regulation
ketohexokinase inhibitor
ketone bodies
knockout
MC4R
Melanocortin-4 receptor
MEK
mitogen-activated protein kinase
knockout impaired
knowledge
lack
learned
lessons
level
levels
ligand
limitations
lipid decomposition
lipid metabolism
lipid synthesis
lipin1
lipogenesis
lipogenic gene
lipogenic gene program
lipolysis
liver
liver confers
liver disease
liver diseases
liver intermediary metabolism
liver lipid metabolism
lncRNA
lncRNAs
localization
localized
long non-coding RNA
LTKOIRS
liver-specific
loose stools
loss
low
lower risk
lowering
lysine sites
lysosomal protein
lysosome systems
mRNA
mTOR
mTOR signaling
mTOR-Akt cascade
mTOR-ULK1
mTORC1
mTORC2
macronutrient metabolism
macronutrients
macronutrients metabolism
male
male mice
males
mammalian
management
manipulation
mass
mechanism
mediates
mediating protein kinase A
mediators
melanocortin-4 receptor
membrane-initiated signal (MISS) pathway
membrane-trafficking
memory
men
menopausal transition
menopause
meta-analysis
metabolic
metabolic activities
metabolic disease
metabolic diseases
metabolic disorders
metabolic regulation
metabolic syndrome
metabolically active
metabolism
miR-484
mice
microRNA-484
mitigating
mitochondria
mitochondria
Introduction
mitochondrial
mitochondrial DNA
mitochondrial biogenesis
mitochondrial dynamic
mitochondrial dynamics
mitochondrial fatty acid oxidation
mitochondrial fission
mitochondrial function
mitochondrial functions
mitochondrial homeostasis
mitochondrial metabolism
mitochondrial quality
mitochondrial regulation
Estrogens
mitochondrial structure
mitochondrial transcription factors
mitophagy
mobility limits
modification
modified
modulates
modulation
molecular mechanism
molecular pathways
molecule
morbidity
mortality
mouse
mouse models
mtDNA
mtDNA polymerase γ subunit
muscle
muscle atrophy
muscle contractile
muscle diseases
muscle dysfunction
muscle growth
muscle injury
muscle loss
muscle mass
muscle recovery
muscle stiffness
muscle strength
muscles
muscular dystrophy
mutations
myoblastic
myokine/cardiokine MG53
myokines
myoregeneration
myosin heavy chain and
myosin heavy chain binding
negatively
net protein gain
neurodegeneration
neurodegenerative diseases
neuronal health
neurons
neuroprotective agent
neurotransmitters
nigrostriatal
non-canonical
non-gland cells
nonalcoholic fatty liver disease
nonreproductive tissue
normal BMI
normalized
normalizing
nuclear receptor
nuclear translocalization
nuclear translocation
numerous
nutrient
nutrients
nutritional
obese
obesity
organelle
outweighs protein
ovariectomized
ovariectomized
PAK
p21
ovariectomized conditions
ovaries
ovary
overactive
overexpression
overfeeding
overweight
oxidative metabolism
oxidative stress
p21-activated kinase
palmitic acid
palmitoylation
pancreatic insulin secretion
pancreatic β cells
pancreatic β-cells
pathological
pathological status
pathways
patients
pear-shaped body fat
peripheral
pharmacological
phenotype
phosphatidylinositol-3-kinase
phosphoenolpyruvate carboxykinase
phosphorates
phosphorylates
phosphorylating
phosphorylation
physical activity therapy
physical exercise
physically active
physiological
physiological condition
physiological functions
physiological homeostasis
physiological secretion
placenta
plasma
plasma membrane
polymorphism
polypeptide
GLP1
glucagon-like peptide-1
GLUT1
glucose transporter 1
GLUT4
glucose transporter 4
GPER
G-protein-coupled estrogen receptor 1
poor glycemic control
post-transcriptionally suppress
post-translational level
postmenopausal
postnatal
postprandial
potentiated
preclinical studies
preclinical trials
premenopausal
premenopausal conditions
premenopause
presence
preservation
preserving
preventing
prevention
primary intention-to-treat group
primary site
primes
processes
processing
production
progression
prominent
promote
promoter
promotes
promoting
proteasome
protection
protective effects
protects
protein
protein catabolism
protein degradation
protein homeostasis
protein kinase A
protein kinases
protein misfolding
protein stability
protein synthesis
protein synthesis pathways
proteins
proteolysis
proteostasis
quality
qualmishness
rapamycin
rapamycin complex 1
rats
recapitulate
receptor
receptor ERα
receptor mutations
receptors
receptors ERα
recruitment
reduced
reduction
reductions
redundant
regions
regulate
regulates
regulating energy
regulation
regulatory fashion
regulatory light chain
replication
represses
reproductive stage
reproductive system
research
resensitize
respiration
response
restored
restraining mitophagy
review
risk
rodents
routes
rs2234693 allele
safety
satellite cell
satellite cell function
saturated
saturated fat
secondary sex
secreted
secretion
section
sensitive
sensitivity
serine/threonine-protein kinase
sex
sex difference
sex hormone
sex-dependent regulation
sex-specific
sexual hormone
sexual hormones
shed light
short-term
side effects
signaling
signaling cascades
signaling events
signaling pathway
signaling pathways
signals
single molecule
skeletal muscle
skeletal muscle index
specific
steatosis
steroids
stimulate
stimulates
strategy
strength
studies
study
subcutaneous 17β-estradiol
subcutaneous adipose tissue
subcutaneously administration
subjects
substrate
sugar
suppress
suppressed
suppresses
suppressing
suppression
susceptible
susceptive
switches
synaptic survival
synthesis
synthesized
systemic
systemic functions
systemic insulin resistance
tab
tab
(A)
target
target genes
targeting
tau
tendency
testing
therapeutic alternatives
therapeutic inefficacy
therapeutic options
therapeutic strategies
therapeutics
thermogenesis
time
time-dependent effects
tiny pool
tissue
tissue-specific
tissues
traditional
traits
transcription
transcription coactivator 2
transcription factor
transcription factors
transcriptional
transcriptional activity
transcriptional processes
transcriptional regulation
translation
translocation
treat
treated with
treating
treatment
triglycerides
turnover
type 2 diabetes
tyrosine
tyrosine sites
ubiquitin
uncoupled protein 1
underpins
unsaturated fat
up-regulate
up-regulation
upregulates
urinary
vascular function
vascular homeostasis
vasculoprotective molecule
vasoreactivity
ventromedial
ventromedial hypothalamic nucleus
visceral
weight loss reduced
white adipose tissue
white adipose tissues
whole-body
women
years
young
younger females
α
ERβ
β-cat/TCF
β-cat/TCF-FGF21 signaling
β3-AR
β3-AR agonist
β3-adrenergic receptor
✉
•
